THE PLUTO STUDY: INTRAVENOUS BELIMUMAB IN CHILDREN WITH SYSTEMIC LUPUS ERYTHEMATOSUS

被引：7

作者：

Ruperto, Nicolino ^{[1
]}

Abud-Mendoza, Carlos ^{[1
]}

Viola, Diego O. ^{[1
]}

Calvo, Inmaculada ^{[1
]}

Levy, Deborah M. ^{[2
]}

Gallegos, Julia Calderon ^{[1
]}

Ferrandiz, Manuel ^{[1
]}

Chasnyk, Vyacheslav ^{[1
]}

Keltsev, Vladimir ^{[1
]}

Anton, Jordi ^{[1
]}

Gastanaga, Maria ^{[1
]}

Shishov, Michael ^{[2
]}

Boteanu, Alina ^{[1
]}

Henrickson, Michael ^{[2
]}

Bass, Damon ^{[3
]}

Clark, Ken ^{[4
]}

Hammer, Anne ^{[3
]}

Ji, Beulah ^{[4
]}

Nino, Antonio ^{[5
]}

Roth, David ^{[3
]}

Struemper, Herbert ^{[6
]}

Wang, Mei-Lun ^{[5
]}

Martini, Alberto ^{[1
]}

Lovell, Daniel J. ^{[2
]}

Brunner, Hermine ^{[2
]}

机构：

[1] Ist Giannina Gaslini, PRINTO, Genoa, Italy

[2] PRCSG, Cincinnati, OH USA

[3] GSK, Philadelphia, PA USA

[4] GSK, Stevenage, Herts, England

[5] GSK, Collegeville, PA USA

[6] GSK, Res Triangle Pk, NC USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷

关键词：

D O I：

10.1136/annrheumdis-2019-eular.4884

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

FRI0181

引用

页码：764 / 765

页数：2

共 50 条

[31] Belimumab in systemic lupus erythematosus: a perspective review
Hui-Yuen, Joyce S.
Li, Xiao Q.
Askanase, Anca D.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2015, 7 (04) : 115 - 121
[32] Update on belimumab for the management of systemic lupus erythematosus
Lutalo, Pamela M. K.
D'Cruz, David P.
EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (11) : 1701 - 1708
[33] Belimumab in systemic lupus erythematosus: an update for clinicians
Kim, Susan S.
Kirou, Kyriakos A.
Erkan, Doruk
THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2012, 3 (01) : 11 - 23
[34] Subcutaneous belimumab in the treatment of systemic lupus erythematosus
Elalouf, Ofir
Keeling, Stephanie O.
Touma, Zahi
IMMUNOTHERAPY, 2018, 10 (13) : 1163 - 1173
[35] Belimumab for systemic lupus erythematosus: breaking through?
Dall'Era, Maria
Wofsy, David
NATURE REVIEWS RHEUMATOLOGY, 2010, 6 (03) : 124 - 125
[36] Baseline Characteristics of Patients Diagnosed with Systemic Lupus Erythematosus Initiating Treatment with Intravenous Belimumab
Bell, Christopher F.
Priest, Julie
Amelio, Justyna
Song, Xue
Kan, Hong
Stott-Miller, Marni
Limone, Brendan
Noxon, Virginia
Costenbader, Karen H.
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[37] EFFECTIVENESS OF INTRAVENOUS BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AT A UK TERTIARY REFERRAL CENTRE
Mallett, Garry
Hession, Charlie
Fernando, Michelle
RHEUMATOLOGY, 2023, 62
[38] PHARMACOKINETICS OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS BELIMUMAB FOR PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Sheikh, S. Z.
Fox, N. L.
Hammer, A. E.
Struemper, H.
Groark, J.
Roth, D.
Gordon, D.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 297 - 298
[39] Systemic Lupus Erythematosus-Associated Serositis Managed With Intravenous Belimumab: A Case Report
Mukkera, Srikanth
Mannem, Maneesh
Chamarti, Karthik
Pillarisetty, Leela
Vulasala, Sai Swarupa
Alahari, Lakshmi
Ammu, Anusha
Mukkera, Akshathh
Vadlapatla, Rajeev K.
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
[40] Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial
Brunner, Hermine, I
Abud-Mendoza, Carlos
Viola, Diego O.
Calvo Penades, Inmaculada
Levy, Deborah
Anton, Jordi
Calderon, Julia E.
Chasnyk, Vyacheslav G.
Ferrandiz, Manuel A.
Keltsev, Vladimir
Paz Gastanaga, Maria E.
Shishov, Michael
Boteanu, Alina Lucica
Henrickson, Michael
Bass, Damon
Clark, Kenneth
Hammer, Anne
Ji, Beulah N.
Nino, Antonio
Roth, David A.
Struemper, Herbert
Wang, Mei-Lun
Martini, Alberto
Lovell, Daniel
Ruperto, Nicolino
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (10) : 1340 - 1348

← 1 2 3 4 5 →